These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33925109)

  • 61. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
    Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
    Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of different kinetic models for dynamic
    Geist BK; Wang J; Wang X; Lin J; Yang X; Zhang H; Li F; Zhao H; Hacker M; Huo L; Li X
    Phys Med Biol; 2020 Feb; 65(4):045001. PubMed ID: 31896098
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Imaging Radiation-Induced Gastrointestinal, Bone Marrow Injury and Recovery Kinetics Using 18F-FDG PET.
    Tang TT; Rendon DA; Zawaski JA; Afshar SF; Kaffes CK; Sabek OM; Gaber MW
    PLoS One; 2017; 12(1):e0169082. PubMed ID: 28052129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
    Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
    Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
    Murayama C; Kawaguchi AT; Kamijo A; Naito K; Kanazawa M; Tsukada H
    PLoS One; 2017; 12(1):e0170911. PubMed ID: 28125711
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The uptake exploration of 68Ga-labeled NGR in well-differentiated hepatocellular carcinoma xenografts: Indication for the new clinical translational of a tracer based on NGR.
    Gao Y; Wang Z; Ma X; Ma W; Zhao M; Fu T; Li G; Wang S; Wang Z; Yang W; Kang F; Wang J
    Oncol Rep; 2017 Nov; 38(5):2859-2866. PubMed ID: 28901442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
    Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
    Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
    Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
    Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
    Ferda J; Ferdová E; Baxa J; Kreuzberg B; Daum O; Třeška V; Skalický T
    Anticancer Res; 2015 Apr; 35(4):2241-6. PubMed ID: 25862885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.
    Wang SB; Wu HB; Wang QS; Zhou WL; Tian Y; Li HS; Ji YH; Lv L
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):324-30. PubMed ID: 25487755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    Tseng JC; Narayanan N; Ho G; Groves K; Delaney J; Bao B; Zhang J; Morin J; Kossodo S; Rajopadhye M; Peterson JD
    PLoS One; 2017; 12(8):e0182689. PubMed ID: 28792505
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
    Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 18F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma.
    Wang HY; Jeng LB; Lin MC; Chao CH; Lin WY; Kao CH
    Clin Imaging; 2013; 37(5):942-6. PubMed ID: 23809917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
    Li P; Liu Q; Wang X; Huang G; Song S
    Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
    Sager S; Akgün E; Uslu-Beşli L; Asa S; Akovali B; Sahin O; Yeyin N; Demir M; Abuqbeitah M; Gülsen F; Sayman H; Sönmezoglu K
    Nucl Med Commun; 2019 May; 40(5):461-468. PubMed ID: 30896544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.